Herpes labialis are a common disease characterized by blisters or erosions on the lips and skin around the mouth and nose. Most cases are caused by herpes simplex virus type 1 (HSV-1), but 10-15% are caused by HSV-2. Studies have shown that the frequency and severity of HSV-1 outbreaks are thought to depend on the effectiveness of immune control of the virus. McKenna showed that people with frequent outbreaks had lower lymphocyte proliferation in vitro in the presence of inactivated HSV-1 and lower levels of interferon-gamma protein in vitro in the presence of inactivated HSV-1 compared with people with infrequent outbreaks. Here, the researchers sought to determine differences in overall immune function, and specifically immune responses to HSV-1, between people infected with HSV-1 and who frequently develop herpes labialis, and people infected with HSV-1 and who do not frequently develop herpes labialis, or people infected with HSV-1 and who have never developed herpes labialis.
The study showed that those with good immune control of HSV-1 infection (fewer outbreaks) differed from those with poor immune control in the following ways: (1) PBMCs had greater proliferation in vitro to HSV-1, HSV-1 infected cell extracts, and Candida species (P < 0.01). (2) PBMCs stimulated in vitro with HSV-1 virus had higher expression of IFNG and five other immune-related genes (each P < 0.05) and lower expression of IL5 and two other immune-related genes (each P < 0.05). Overall, higher expression levels of IFNG and lower expression levels of IL5 in PBMCs were associated with fewer herpes labialis episodes in the presence of HSV-1, and a single topical application of SADBE to the arm of subjects with frequent herpes labialis episodes improved the immune response to HSV-1.
Figure 1. PBMC normalized proliferation in the three test stimuli taken together (HSV-1-infected cell extracts, inactivated HSV-1, and Candida extract). (McTavish H, et al., 2019)
Customer Q&As
What is Wild-Type Herpes Simplex Virus 1 (HSV-1) and why is it used for research purposes?
A: Wild-Type HSV-1 refers to the original, unmodified form of the herpes simplex virus type 1. It is used for research to understand the virus's biology, pathogenesis, replication, and the development of therapeutics and vaccines against HSV-1.
How are Wild-Type HSV-1 products typically used in research studies?
A: Wild-Type HSV-1 products are often used to infect cell cultures for investigating viral replication, gene expression, and the cellular response to infection. They can also be used to study viral entry mechanisms, the establishment of latency, and the development of antiviral drugs.
What is herpes simplex?
A: Herpes simplex is a virus that causes skin infections. This infection can last a lifetime and cause painful or itchy sores and blisters. Herpes simplex virus usually does not cause serious problems. However, it can be dangerous for babies and people with weakened immune systems.
What is the difference between HSV-1 and HSV-2?
A: HSV-1 mostly spreads by oral contact and causes infections in or around the mouth (oral herpes or cold sores). HSV-2 spreads by sexual contact and causes genital herpes.
What is the genome size of HSV?
A: The HSV genome spans approximately 150,000 bp and consists of two unique segments, termed unique long (UL) and unique short (US), and terminal inverted repeats found at either end of them, termed repeat long (RL) and repeat short (RS).
Ask a Question
Customer Reviews
Reliable Product
The reliability and consistency of the virus strain have been exceptional, allowing me to conduct my experiments with confidence.
Top-Notch Product
The virus strains they offer are top-notch, exhibiting robust replication kinetics and exhibiting remarkable cellular tropism.
Write a Review